Literature DB >> 15634946

Human cytomegalovirus UL144 gene polymorphisms in congenital infections.

Olivier Picone1, Jean-Marc Costa, Marie-Laure Chaix, Yves Ville, Christine Rouzioux, Marianne Leruez-Ville.   

Abstract

The human cytomegalovirus (HCMV) UL144 gene is a tumor necrosis factor-like receptor with the potential to affect HCMV virulence. HCMV strains display genetic variability in the UL144 region, and the analysis of a potential link between UL144 gene polymorphisms and disease severity has scarcely been studied. However, a correlation between the UL144 genotype and congenital-disease outcome has been reported in one previous study, with the observation that all asymptomatic infants had a single UL144 genotype. In order to confirm or refute this finding, we determined the UL144 polymorphisms of HCMV strains recovered from the amniotic fluids of 38 infected fetuses and compared them to HCMV strains obtained from 30 viremic adult controls. The UL144 sequences were distributed among five genotypes (A, B, C, AC, and AB), as previously described. We observed similar percentages of the three major genotypes A (37%), B (33%), and C (27%) in our population. The UL144 genotype distributions were similar among the group of infected adults and the group of infected fetuses and among symptomatic and asymptomatic fetuses (P < 0.05). In our series, all five UL144 genotypes could be vertically transmitted from mothers to fetuses, and all could cause symptomatic congenital infection. We concluded that determination of UL144 polymorphisms in cases of congenital infection is not relevant, since it is unlikely to help predict the outcome of the infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15634946      PMCID: PMC540124          DOI: 10.1128/JCM.43.1.25-29.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus.

Authors:  C A Benedict; K D Butrovich; N S Lurain; J Corbeil; I Rooney; P Schneider; J Tschopp; C F Ware
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

Review 2.  The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death.

Authors:  C A Smith; T Farrah; R G Goodwin
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

3.  Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates.

Authors:  N S Lurain; K S Kapell; D D Huang; J A Short; J Paintsil; E Winkfield; C A Benedict; C F Ware; J W Bremer
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  Prenatal indicators of congenital cytomegalovirus infection.

Authors:  T Lazzarotto; S Varani; B Guerra; A Nicolosi; M Lanari; M P Landini
Journal:  J Pediatr       Date:  2000-07       Impact factor: 4.406

5.  Prenatal diagnostic and prognostic value of human cytomegalovirus load and IgM antibody response in blood of congenitally infected fetuses.

Authors:  M Grazia Revello; M Zavattoni; A Sarasini; F Baldanti; C De Julio; L De-Giuli; U Nicolini; G Gerna
Journal:  J Infect Dis       Date:  1999-10       Impact factor: 5.226

6.  Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses.

Authors:  M G Revello; M Zavattoni; M Furione; F Baldanti; G Gerna
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

7.  Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus.

Authors:  Lucy Rasmussen; Aimee Geissler; Mark Winters
Journal:  J Infect Dis       Date:  2003-02-24       Impact factor: 5.226

8.  Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma.

Authors:  Marianne Leruez-Ville; Marie Ouachée; Richard Delarue; Anne-Sophie Sauget; Stéphane Blanche; Agnès Buzyn; Christine Rouzioux
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains.

Authors:  T A Cha; E Tom; G W Kemble; G M Duke; E S Mocarski; R R Spaete
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Transgenic expression of the activating natural killer receptor Ly49H confers resistance to cytomegalovirus in genetically susceptible mice.

Authors:  Seung-Hwan Lee; Ahmed Zafer; Yves de Repentigny; Rashmi Kothary; Michel L Tremblay; Philippe Gros; Pascale Duplay; John R Webb; Silvia M Vidal
Journal:  J Exp Med       Date:  2003-02-17       Impact factor: 14.307

View more
  21 in total

1.  Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis.

Authors:  Jens-Uwe Vogel; Jürgen Otte; Frank Koch; Hermann Gümbel; Hans Wilhelm Doerr; Jindrich Cinatl
Journal:  Med Microbiol Immunol       Date:  2012-06-06       Impact factor: 3.402

2.  Monoclonal antibodies to B and T lymphocyte attenuator (BTLA) have no effect on in vitro B cell proliferation and act to inhibit in vitro T cell proliferation when presented in a cis, but not trans, format relative to the activating stimulus.

Authors:  M Zhang; K Howard; A Winters; S Steavenson; S Anderson; S Smelt; G Doellgast; C Sheelo; J Stevens; H Kim; A Hamburger; A Sein; D J Caughey; F Lee; H Hsu; G Siu; F R Byrne
Journal:  Clin Exp Immunol       Date:  2010-11-16       Impact factor: 4.330

Review 3.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

4.  Human cytomegalovirus UL144 is associated with viremia and infant development sequelae in congenital infection.

Authors:  Allison Waters; Jaythoon Hassan; Cillian De Gascun; Ghia Kissoon; Susan Knowles; Eleanor Molloy; Jeff Connell; William W Hall
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

5.  Overview of the diagnosis of cytomegalovirus infection.

Authors:  S A Ross; Z Novak; S Pati; S B Boppana
Journal:  Infect Disord Drug Targets       Date:  2011-10

6.  Distribution of UL144, US28 and UL55 genotypes in Polish newborns with congenital cytomegalovirus infections.

Authors:  E Paradowska; M Studzińska; D Nowakowska; J Wilczyński; M Rycel; P Suski; Z Gaj; B Kaczmarek; Z Zbróg; Z J Leśnikowski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

7.  Polymorphisms and features of cytomegalovirus UL144 and UL146 in congenitally infected neonates with hepatic involvement.

Authors:  Gangqiang Guo; Liang Zhang; Sisi Ye; Yingying Hu; Baoqing Li; Xiangwei Sun; Chenchen Mao; Jianfeng Xu; Yiping Chen; Lifang Zhang; Xiangyang Xue
Journal:  PLoS One       Date:  2017-02-21       Impact factor: 3.240

Review 8.  Strain Variation and Disease Severity in Congenital Cytomegalovirus Infection: In Search of a Viral Marker.

Authors:  Ravit Arav-Boger
Journal:  Infect Dis Clin North Am       Date:  2015-07-04       Impact factor: 5.982

9.  Genetic polymorphism of UL144 open reading frame of human cytomegalovirus DNA detected in colon samples from infants with Hirschsprung's disease.

Authors:  Zhi-Qin Mao; Ying Huang; Mei Sun; Qiang Ruan; Ying Qi; Rong He; Yu-Jing Huang; Yan-Ping Ma; Yao-Hua Ji; Zheng-Rong Sun; Hong Gao
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

10.  CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.

Authors:  John R Šedý; Ryan L Bjordahl; Vasileios Bekiaris; Matthew G Macauley; Brian C Ware; Paula S Norris; Nell S Lurain; Chris A Benedict; Carl F Ware
Journal:  J Immunol       Date:  2013-06-12       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.